EP2651396
Lyfjasamsetningar sem innihalda alísporívír
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
12.12.2011EP published:
12.7.2017EP application number:
11794739.0
EP translation filed:
11.10.2017Grant published:
15.11.2017EPO information:
European Patent Register
Max expiry date:
11.12.2031Expiry date:
11.12.2020
Title:
PHARMACEUTICAL COMPOSITIONS COMPRISING ALISPORIVIR
Timeline
Today
12.12.2011EP application
12.7.2017EP Publication
11.10.2017Translation submitted
15.11.2017Registration published
11.12.2020Expires
Owner
Name:
Novartis AGAddress:
Lichtstrasse 35, 4056, Basel, CH
Name:
Debiopharm S.A.Address:
Forum "Après-Demain" Chemin Messidor 5-7 CP 5911, 1002, Lausanne, CH
Inventor
Name:
GONCALVES, ElisabeteAddress:
Basel, CH
Name:
RAPP, KarinAddress:
Basel, CH
Name:
SUTTER, BertrandAddress:
Basel, CH
Name:
STOWASSER, FrankAddress:
Basel, CH
Name:
TRUPP, BjoernAddress:
Basel, CH
Name:
CHABAUT, SebastianAddress:
Lausanne, CH
Name:
THORENS, JulienAddress:
Lausanne, CH
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
422499 PDate:
13.12.2010Country:
US
Number:
PCT/IB2011/000319Date:
18.2.2011Country:
WO
Number:
PCT/IB2011/000653Date:
25.3.2011Country:
WO
Classification
Categories:
A61K 9/107, A61K 9/48, A61K 47/10, A61K 47/14, A61K 47/22, A61K 47/26, A61K 9/00, A61K 38/13
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 1.11.2017
Expires: 11.12.2018
Payer: Árnason Faktor
Number: 8
Paid: 26.11.2018
Expires: 11.12.2019
Payer: Árnason Faktor
Number: 9
Paid: 26.11.2019
Expires: 11.12.2020
Payer: Árnason Faktor